Some of the latest research advancements in the field of diabetes presented at the American Diabetes Association (ADA) virtual meeting included the long-awaited GRADE findings, heart…
Three patent families have been filed to cover novel hormonal combinations: pramlintide-exenatide and glucagon-exenatide – both combinations demonstrated promising effects in obesity treatmentAdministering short-acting hormones by a pump…